Industrial and scientific project

Targeting Hypoxia with heavy ions to gain control of RadiOresistant Cancers

Partner: EP Permed - European Partnership for Pesonalized Medicine Period: March 2025 – February 2028

Project information

MOX responsible
Paolo Zunino
Team
Francesca Arceci; Nunzio Dimola; Cristina Macaluso; Piermario Vitullo;
Start date
March 2025
End date
February 2028

Abstract

Tumor hypoxia drives resistance to photon radiotherapy, making carbon ion RT a promising alternative, yet patient selection rarely accounts for hypoxia due to the lack of non-invasive biomarkers. The Hi-ROC project aims to develop multimodal hypoxia biomarkers and digital-twin tools to enable personalized selection between photon RT and CIRT and to guide future clinical trials.